Barton P. Bandy - 01 Jul 2022 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
President and CEO, Director
Signature
/s/ Barton P. Bandy
Issuer symbol
RSLS
Transactions as of
01 Jul 2022
Net transactions value
-$6,293
Form type
4
Filing time
06 Jul 2022, 16:03:12 UTC
Previous filing
06 Jun 2022
Next filing
11 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Sale $6,293 -11,442 -1.4% $0.5500 784,772 01 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 22, 2021, Mr. Bandy was awarded an aggregate of 1,186,006 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.